NFKB1 and neoplasm: The use of TPL disrupts the H19/MiR-204-5p/NF-κB/FLIP axis, resulting in the non-proteasome-mediated degradation of FLIPS and heightened apoptosis in TNF-α-stimulated tumor cells [56, 57].